Three BC Cancer Agency associated research projects receive millions in Canadian funding

13/10/2017

Three research projects associated with BC Cancer Agency scientists were recently awarded millions of dollars in infrastructure funding from the Government of Canada.

Use this image as both the current Page Image and for News listings

Drs. François Bénard, Brad Nelson and Marcel Bally

On October 12, the Ministry of Science announced a contribution of more than $550 million through the Canadian Foundation for Innovation (CFI) to provide funding for 117 new infrastructure projects at 61 universities, colleges and research hospitals across the country.

BC Cancer Agency recipients include, Dr. François Bénard, Dr. Brad Nelson and (through a project led by Dr. Artem Cherkasov from Vancouver Prostate Centre and Dr. Natalie Strynadka from the University of British Columbia), Dr. Marcel Bally.

Dr. Bénard's work in the production of rare isotopes for cancer therapy at TRIUMF (Canada's national laboratory for particle and nuclear physics and accelerator-based science located at UBC) will receive $3.95 million. Dr. Nelson's project, Engineering Precision Immunotherapies for Cancer (EPIC), will receive $4 million. And Dr. Cherkasov's work with Dr. Bally will receive $9 million for Accelerated Drug Discovery Using Clinical Translation (ADDUCT).

A full list of the all 2017 funded projects is available online at Innovation.ca.